YPEL5 (yippee-like 5 (Drosophila)) by Güpür, G & Muyan, M
  
 
 
   
Gene Section 
Short Communication 
 
Atlas Genet Cytogenet Oncol Haematol. 2014; 19(1) 41 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology 
INIST-CNRS 
 
OPEN ACCESS JOURNAL 
YPEL5 (yippee-like 5 (Drosophila)) 
Gizem Güpür, Mesut Muyan 
Department of Biological Sciences, Middle East Technical University, Ankara, Turkey (GG, MM) 
 
Published in Atlas Database: April 2014 
Online updated version : http://AtlasGeneticsOncology.org/Genes/YPEL5ID44614ch2p23.html 
DOI: 10.4267/2042/55377 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. 
© 2015 Atlas of Genetics and Cytogenetics in Oncology and Haematology 
 
Abstract 
Review on YPEL5, with data on DNA/RNA, on the 
protein encoded and where the gene is implicated. 
Identity 
Other names: CGI-127 
HGNC (Hugo): YPEL5 
Location: 2p23.1 
Local order 
From centromere to telomere: FAM179A-C2orf71-
CLIP4-ALK-LOC101929418-YPEL5-LBH-
LOC102723594-LOC285043. 
DNA/RNA 
Description 
YPEL5 has 5 exons. 
Transcription 
YPEL5 has 4 transcript variants. 
Transcript variant 1: 2639 bp mRNA (NCBI 
Reference Sequence: NM_001127401.1). 
Transcript variant 2: 2578 bp mRNA (NCBI 
Reference Sequence: NM_001127400.1). 
Transcript variant 3: 2342 bp mRNA (NCBI  
 
 
Reference Sequence: NM_001127399.1). 
Transcript variant 4: 2281 bp mRNA (NCBI 
Reference Sequence: NM_016061.2). 
Protein 
Description 
All 4 transcript variants code for the same protein. 
Protein yippee-like 5 [Homo sapiens] (NCBI 
Reference Sequence: NP_001120873.1); 121 aa 
protein. 
Expression 
In human, YPEL5 is expressed in the brain, heart, 
kidney, lung, pancreas, placenta, skeletal muscle, 
colon, ovary, leukocyte, prostate, small intestine, 
spleen, testis, thymus, bone marrow, leukocyte, 
tonsil, fetal brain, fetal heart, fetal kidney, fetal 
liver, fetal lung, fetal skeletal muscle, fetal spleen 
and fetal thymus (Hosono et al., 2004). 
Localisation 
Localized in the nucleus in a diffuse pattern, Ypel5 
re-localizes in a region between two spindle poles, 
likely on the mitotic spindle during mitosis, 
suggesting a possible role in cell division (Hosono 
et al., 2004). Ypel5 is localized in the nucleus and 
on the centrosome during interphase.  
 
 
Local order of YPEL5 is shown together with leading and subsequent genes on chromosome 2. 
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Boxes show exons; filled boxes correspond to coding exons, empty boxes indicate noncoding exons. Lines connecting the boxes 
represent introns. 
 
 
At prophase, it is detected at spindle poles, while 
during metaphase and early anaphase it becomes 
associated with mitotic spindle. At mid-anaphase 
and telophase it is localized in the spindle midzone. 
During cytokinesis, Ypel5 is observed only on the 
midbody (Hosono et al., 2010). 
Function 
Knock-down of YPEL5 in Cos7 cells results in the 
suppression of cell growth by extending durations 
of G1 and G2+M phases. Ypel5 was shown to 
interact, yet by an unknown mechanism, with Ran 
binding protein in the microtubule organizing 
center (RanBPM) through SPRY domain of 
RanBPM. Ypel5 could also bind RanBP10, paralog 
of RanBPM. Ypel5 is suggested to function in cell 
division and cell cycle progression through 
interactions with RanBPM and RanBP10 (Hosono 
et al., 2010). 
Furthermore, knockdown of YPEL5 homolog Ypel-
b in medaka fish causes a malformation in embryos. 
Normal embryogenesis is interrupted in these 
embryos as a result of suppression of cell 
proliferation and induction of apoptosis (Hosono et 
al., 2010). 
YPEL5 is expressed in human peripheral T cells in 
G0 stage and it is down-regulated upon activation 
by immobilized anti-CD3. In addition, transfection 
of YPEL5 into HeLa cells causes a decrease in 
cellular proliferation (Jun et al., 2007). 
Homology 
In human, YPEL5 has 4 paralogs; YPEL1, YPEL2, 
YPEL3 and YPEL4. Ypel5 has 49.5% aminoacid 
sequence identity with Ypel1; 48.5% with Ypel2; 
43.8% with Ypel3 and 44.6% with Ypel4 (Hosono 
et al., 2004). 
Ypel5 is an ortholog of Drosophila Yippee protein 
and has 70.8% aminoacid sequence identity to 
Yippee. There are 100 YPEL family genes in 68 
species including mammal, bird, amphibia, fish, 
protochordate, insect, nematode, coelenterate, 
echinoderm, protozoan, plant, and fungi. In this 
diverge range of organisms, YPEL family proteins 
shows a high level of homology with many 
identical residues. Thus, a consensus sequence is 
deduced as follows: C-X2-C-X19-G-X3-L-X5-N-X13-
G-X8-C-X2-C-X4-GWXY-X10-K-X6-E. In the 
consensus sequence, the number of non-consensus 
residues, designated as X, is identical for all species 
examined (Hosono et al., 2004). 
Implicated in 
Lung cancer 
Note 
Treatment of A549 human non-small cell lung 
carcinoma cell line with ethanolic extract of 
Descurainia sophia seeds causes a dose dependent 
up-regulation in YPEL5 mRNA levels (Kim et al., 
2013). 
Prognosis 
YPEL5 is found to be related to survival in lung 
cancer patients with a hazard ratio of 0.62 (Kim et 
al., 2013). 
Chronic lymphocytic leukemia (CLL) 
Abnormal protein 
Reciprocal RNA chimeras of YPEL5 and PPP1CB 
genes are recurrently and exclusively detected in 
chronic lymphocytic leukemia. YPEL5/PPP1CB 
and PPP1CB/YPEL5 chimeras form as a result of 
an intergenic splicing event and there is no genomic 
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basis for this fusion which marks a possible 
breakpoint.  
YPEL5/PPP1CB RNA chimera results in the 
formation of a truncated PPP1CB protein which 
shows a decreased phosphatase activity.  
This RNA chimeric fusion product acts a dominant 
negative protein that inhibits the function of wild 
type PPP1CB protein.  
This results in an enhanced proliferation and colony 
formation in B-CLL-related cells (Velusamy et al., 
2013). 
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